Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.48 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.48 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | BTK | Q06187 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL62434 | 1.00 | SMN1; SMN2 (0.50) | SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL10137131 | 0.93 | SMN1; SMN2 (0.58) | SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL17099600 | 0.91 | BTK (0.49) | SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL17099599 | 0.91 | BTK (0.49) | SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL595592 | 0.91 | BTK (0.49) | SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL12265848 | 0.91 | SMN1; SMN2 (0.44) | SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL595591 | 0.91 | BTK (0.49) | SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL595590 | 0.91 | BTK (0.49) | SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL24906947 | 0.90 | CHRNB2 (0.52) | SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL2824374 | 0.90 | CHRNB2 (0.52) | SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 457 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4357389-B1 | POLYESTER RESIN COMPRISING REGENERATED BIS(2-HYDROXYETHYL)TEREPHTHALATE AND FILM | SK CHEMICALS CO LTD (KR) | 2026-05-27 | — | — | EP | claimed |
| CN-122055404-A | Polyester heat-shrinkable film with improved shrink properties | SK化学公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260109809-A1 | POLYESTER RESIN AND MOLDED ARTICLE MANUFACTURED THEREFROM | SK CHEMICALS CO LTD (KR) | 2026-04-23 | — | — | US | claimed |
| US-20260109850-A1 | POLYESTER RESIN BLEND, POLYESTER FILM AND PREPARATION METHOD THEREOF | SK CHEMICALS CO LTD (KR) | 2026-04-23 | — | — | US | claimed |
| EP-4722279-A1 | ORIENTED POLYESTER FILM AND MANUFACTURING METHOD THEREFOR | SK Chemicals Co., Ltd. (KR) | 2026-04-08 | — | — | EP | claimed |
| US-20260049212-A1 | POLYESTER RESIN MIXTURE, METHOD FOR PREPARING SAME, AND POLYESTER FILM PREPARED THEREFROM | SK CHEMICALS CO LTD (KR) | 2026-02-19 | — | — | US | claimed |
| EP-4696735-A1 | POLYESTER RESIN AND PREPARATION METHOD THEREFOR | SK Chemicals Co., Ltd. (KR) | 2026-02-18 | — | — | EP | claimed |
| EP-4667506-A1 | POLYESTER RESIN AND MOLDED ARTICLE MANUFACTURED THEREFROM | SK Chemicals Co., Ltd. (KR) | 2025-12-24 | — | — | EP | claimed |
| US-20250382413-A1 | POLYESTER RESIN AND PREPARATION METHOD THEREFOR | SK CHEMICALS CO LTD (KR) | 2025-12-18 | — | — | US | claimed |
| US-12435024-B2 | Process for treating polyester methanolysis depolymerization product streams | EASTMAN CHEMICAL COMPANY (US) | 2025-10-07 | — | — | US | claimed |
| US-5406004-A | From ester using a copper catalyst | EASTMAN CHEMICAL COMPANY (US) | 1995-04-11 | — | — | US | claimed |
| US-5395986-A | Hydrogenation of dialkyl cyclohexanedicarboxylate using copper or group VIII compound catalysts; high trans configuration to cis ratio | EASTMAN CHEMICAL COMPANY (US) | 1995-03-07 | — | — | US | claimed |
| US-5395991-A | Regeneration of hydrogenation catalyst | EASTMAN CHEMICAL COMPANY (US) | 1995-03-07 | — | — | US | claimed |
| US-5387753-A | Catalytic hydrogenating vapor stream unsaturated esters, diesters or lactones in presence of coppor containing catalyst , reactivating the copper catalyst by a stream of hydrogen gas free of reactants | EASTMAN CHEMICAL COMPANY (US) | 1995-02-07 | — | — | US | claimed |
| US-5387752-A | Catalytic hydrogenation of a dialkylcyclohexanedicarboxylate | EASTMAN CHEMICAL COMPANY (US) | 1995-02-07 | — | — | US | claimed |
| WO-1994029259-A1 | PREPARATION OF DIMETHYL CYCLOHEXANEDICARBOXYLATES | EASTMAN CHEMICAL COMPANY (US) | 1994-12-22 | — | — | WO | claimed |
| WO-1994029260-A1 | LOW PRESSURE PROCESS FOR THE HYDROGENATION OF DIMETHYL BENZENEDICARBOXYLATES TO THE CORRESPONDING DIMETHYL CYCLOHEXANEDICARBOXYLATES | EASTMAN CHEMICAL COMPANY (US) | 1994-12-22 | — | — | WO | claimed |
| US-5319129-A | Low-pressure hydrogenation of a dimethyl benzenedicarboxylate using a catalyst having a specific weight and dispersion depth of palladium and crystal structure of the alumina support | EASTMAN KODAK COMPANY (US) | 1994-06-07 | — | — | US | claimed |
| US-5286903-A | Process for the preparation of cyclohexanedicarboxylic acids | EASTMAN KODAK COMPANY (US) | 1994-02-15 | — | — | US | claimed |
| US-5286898-A | Using group 8 metal hydrogenation catalyst | EASTMAN KODAK COMPANY (US) | 1994-02-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12435024-B2 | Process for treating polyester methanolysis depolymerization product streams | ADH1A, ADH1C, ADH5 | SMN1; SMN2 3736/4885CHRNB2 3827/4885CHRNA4 4074/4885 |
| US-20260109809-A1 | POLYESTER RESIN AND MOLDED ARTICLE MANUFACTURED THEREFROM | TUFM, RTF2, MRM1 | SMN1; SMN2 2151/4885CHRNB2 4541/4885CHRNA4 4583/4885 |
| US-20260109850-A1 | POLYESTER RESIN BLEND, POLYESTER FILM AND PREPARATION METHOD THEREOF | RICTOR, CUTA, DEPTOR | SMN1; SMN2 3479/4885CHRNB2 3092/4885CHRNA4 3284/4885 |
| US-20260049212-A1 | POLYESTER RESIN MIXTURE, METHOD FOR PREPARING SAME, AND POLYESTER FILM PREPARED THEREFROM | ALKBH3, BHMT2, ALKBH2 | SMN1; SMN2 3753/4885CHRNB2 2482/4885CHRNA4 2818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.